The key to better osteoarthritis treatments: clinical trials explained with Dr Karen Bracken
Joint ActionShow Notes
Welcome to Season 6 of the Joint Action Podcast and the first episode of 2025! We're kicking off with a crucial topic in advancing osteoarthritis treatment: understanding clinical trials.
Clinical trials are vital for developing new treatments for osteoarthritis, yet many people are mystified by the process. Why participate? What are the benefits? What are the risks? In this episode, we break it all down with Dr. Karen Bracken, Clinical Trial Program Lead at the Kolling Institute, University of Sydney. With over 20 years of experience managing clinical trials, Karen provides an insider’s perspective on the motivations, processes, and considerations involved in clinical research.
Join us as we explore: The potential benefits of participating in clinical trials, such as access to new treatments and contributing to science. Key considerations, including time commitments and informed consent. How clinical trials are designed to prioritise participant safety and generate reliable evidence. Misconceptions about clinical trials and how they differ from reality.
We also discuss exciting ongoing trials, including the ATLAS study for knee osteoarthritis, the TOPS osteoarthritis prevention study, and the MARVEL study exploring the impact of pentosan polysulfate sodium on knee pain.
Whether you're curious about clinical trials or considering participating in one, this episode offers valuable insights to guide your journey.
RESOURCES
To learn more about osteoarthritis clinical trials, visit our website: www.osteoarthritisresearch.com.au
To learn more about the Osteoarthritis Research Participant Network or to join, click here: www.osteoarthritisresearch.com.au/oa-participant-network
Current osteoarthritis studies: The ATLAS study: www.osteoarthritisresearch.com.au/atlas-study-overview TOPS study: www.osteoarthritisresearch.com.au/tops-study-overview The MaRVeL study: www.osteoarthritisresearch.com.au/marvel-study-overview
Previous podcast episodes S05E05 - Core outcome sets for osteoarthritis trials with Prof. Toby Smith
Websites OMERACT - Outcome Measures in Rheumatology: www.omeract.org Hosted on Acast. See acast.com/privacy for more information.
More from Joint Action
On this special World Arthritis Day episode of Joint Action, we are bringing together some of the most moving moments from our patient stories series, where real people share what it is like to live with osteoarthritis, and more importantly, what they did about it.
Do supplements really help with osteoarthritis, or are we wasting our money? On this week's episode of Joint Action, Associate Professor Joanna Harnett and Dr Jocelyn Bowden join Professor David Hunter to cut through the noise on complementary medicines, exploring what the evidence actually shows and how to make informed decisions about supplement use for osteoarthritis.
What does it really mean to live with hand osteoarthritis, and how do you stay active and engaged in life when your hands are constantly painful? On this week's episode of Joint Action, Giovanna Lever joins Professor David Hunter to share her personal journey living with hand osteoarthritis, diagnosed at 45 after years of struggling with pain, and what it has meant for her work, travel, and family life.
Is platelet-rich-plasma (PRP) a game changer for osteoarthritis, or is the evidence still catching up with the hype? On this week's episode of Joint Action, Dr Hamish Osborne joins Professor David Hunter to cut through the noise on PRP exploring what the research currently shows, where the gaps in evidence lie, and how patients and clinicians can navigate the decision together.
Do your knees crack, pop, or creak when you move? On this week's episode of Joint Action, Associate Professor Danilo De Oliveira Silva joins Professor David Hunter to explain what those sounds actually mean, whether they are something to worry about, and what the research tells us about the relationship between noisy knees and osteoarthritis.